Advancing HBV and HDV Screening: Applying New Guidelines to Clinical Practice

CAN-eng

$0

gratuit

Mainpro+

15 min

Maladie infectieuse

0.25 Credits

APPRENDRE ENCORE PLUS

Description du cours

Hepatitis B and hepatitis D are important causes of chronic liver disease, yet many individuals remain undiagnosed until advanced disease develops. This program aims to support clinicians in implementing the recent updates to the CASL/AMMI Canada guidelines on the screening, vaccination, and treatment of hepatitis B (HBV) and hepatitis D (HDV). Using a patient case, this program will highlight what has changed and how to incorporate these changes into practice.

Course Features: 

– 1 video lecture, 
– 4 interactive quizzes, 
– 1 downloadable resource.  

Content Covered: 

Module: Advancing HBV and HDV Screening: Applying New Guidelines to Clinical Practice. 

This program has received an unrestricted educational grant or in-kind support from Gilead.

Détails du cours

Date d'expiration : 2027-07-22

Métiers: Médecin

Faculté

  • Alnoor Ramji, MD, FRCP(C)
  • Hsiao-Ming Jung, MD, CM, CCFP, CFPC
  • Rachel Talavlikar, MD, CCFP

Accréditation

This activity meets the certification criteria of the College of Family Physicians of Canada and the Quebec College of Family Physicians, a continuing professional development accrediting organization recognized by the Collège des médecins du Québec and has been approved for up to 0.25 Mainpro+® Certified Activity credit(s).  

Cert+ Program ID#: 304025-001

Objectif(s) d'apprentissage

Upon completion of this continuing education program, participants will be better able to:

  • Identifier patients who should be screened for hepatitis B and D based on updated recommendations
  • Décrire the key updates to the 2025 CASL/AMMI Canada guidelines to HBV and HDV screening and management